avapro has been researched along with Cardiotoxicity in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, it is still needed to search for a safe and effective therapy that can opposite DOX-induced cardiotoxicity." | 1.51 | Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways. ( El-Said, NT; Mohamed, EA; Taha, RA, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tepebaşi, MY | 1 |
| Aşci, H | 1 |
| Coşan, S | 1 |
| Sevük, MA | 1 |
| Karakuyu, NF | 1 |
| Özmen, Ö | 1 |
| El-Said, NT | 1 |
| Mohamed, EA | 1 |
| Taha, RA | 1 |
2 other studies available for avapro and Cardiotoxicity
| Article | Year |
|---|---|
Irbesartan has a curative effect on lipopolysaccharide-induced cardiotoxicity by antioxidant and antiapoptotic pathways.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Irbesartan; Lipopolysaccharides; Oxida | 2023 |
Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
Topics: Animals; Cardiotoxicity; Caspase 3; Doxorubicin; Electrocardiography; Irbesartan; Male; NF-kappa B; | 2019 |